Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8864475rdf:typepubmed:Citationlld:pubmed
pubmed-article:8864475lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8864475lifeskim:mentionsumls-concept:C0020179lld:lifeskim
pubmed-article:8864475lifeskim:mentionsumls-concept:C0020663lld:lifeskim
pubmed-article:8864475lifeskim:mentionsumls-concept:C0152360lld:lifeskim
pubmed-article:8864475lifeskim:mentionsumls-concept:C0037659lld:lifeskim
pubmed-article:8864475lifeskim:mentionsumls-concept:C0205216lld:lifeskim
pubmed-article:8864475lifeskim:mentionsumls-concept:C0597879lld:lifeskim
pubmed-article:8864475pubmed:issue2lld:pubmed
pubmed-article:8864475pubmed:dateCreated1997-1-15lld:pubmed
pubmed-article:8864475pubmed:abstractTextThe hypothalamic lateral tuberal nucleus (NTL) can be recognized in man and higher primates, only. The function of this nucleus is unknown, but the NTL is affected in a variety of human neurodegenerative diseases, including Huntington's disease (HD) and Alzheimer's disease. In the present study we demonstrate an abundant presence of somatostatin 1-12 (SST1-12) immunoreactivity in both neurites and perikarya of the NTL. This immunoreactivity could be visualized best after microwave pretreatment. In HD brains, NTL SST1-12 immunoreactivity was greatly reduced, providing further evidence of the presence of SST1-12 as an intrinsic neuropeptide in the NTL. Although striatal SST neurons escape destruction in HD, our study demonstrates that not all SST neurons are resistant to the degenerative process in this disease.lld:pubmed
pubmed-article:8864475pubmed:languageenglld:pubmed
pubmed-article:8864475pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8864475pubmed:citationSubsetIMlld:pubmed
pubmed-article:8864475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8864475pubmed:statusMEDLINElld:pubmed
pubmed-article:8864475pubmed:monthJullld:pubmed
pubmed-article:8864475pubmed:issn0006-8993lld:pubmed
pubmed-article:8864475pubmed:authorpubmed-author:SwaabD FDFlld:pubmed
pubmed-article:8864475pubmed:authorpubmed-author:KremerH PHPlld:pubmed
pubmed-article:8864475pubmed:authorpubmed-author:van de NesJ...lld:pubmed
pubmed-article:8864475pubmed:authorpubmed-author:TimmersH JHJlld:pubmed
pubmed-article:8864475pubmed:issnTypePrintlld:pubmed
pubmed-article:8864475pubmed:day29lld:pubmed
pubmed-article:8864475pubmed:volume728lld:pubmed
pubmed-article:8864475pubmed:ownerNLMlld:pubmed
pubmed-article:8864475pubmed:authorsCompleteYlld:pubmed
pubmed-article:8864475pubmed:pagination141-8lld:pubmed
pubmed-article:8864475pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8864475pubmed:meshHeadingpubmed-meshheading:8864475-...lld:pubmed
pubmed-article:8864475pubmed:meshHeadingpubmed-meshheading:8864475-...lld:pubmed
pubmed-article:8864475pubmed:meshHeadingpubmed-meshheading:8864475-...lld:pubmed
pubmed-article:8864475pubmed:meshHeadingpubmed-meshheading:8864475-...lld:pubmed
pubmed-article:8864475pubmed:meshHeadingpubmed-meshheading:8864475-...lld:pubmed
pubmed-article:8864475pubmed:meshHeadingpubmed-meshheading:8864475-...lld:pubmed
pubmed-article:8864475pubmed:meshHeadingpubmed-meshheading:8864475-...lld:pubmed
pubmed-article:8864475pubmed:meshHeadingpubmed-meshheading:8864475-...lld:pubmed
pubmed-article:8864475pubmed:meshHeadingpubmed-meshheading:8864475-...lld:pubmed
pubmed-article:8864475pubmed:meshHeadingpubmed-meshheading:8864475-...lld:pubmed
pubmed-article:8864475pubmed:year1996lld:pubmed
pubmed-article:8864475pubmed:articleTitleSomatostatin 1-12 immunoreactivity is decreased in the hypothalamic lateral tuberal nucleus of Huntington's disease patients.lld:pubmed
pubmed-article:8864475pubmed:affiliationDepartment of Neurology, University of Nijmegen, The Netherlands.lld:pubmed
pubmed-article:8864475pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8864475lld:pubmed